Physician profile
Ryan C Su
NPI 1487383675
$8,994.40
in general payments reported to CMS, 2019-2025
54 companies · $2,416 in 2025
The $2,416 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $934 · 2023: $2,701 · 2024: $2,943 · 2025: $2,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,060.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,134.27 | 2022-2025 | |
| Novo Nordisk INC | $813.48 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $740.14 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $545.36 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $521.81 | 2022-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $494.14 | 2022-2025 | Xifaxan, Trulance, Relistor |
| Novartis Pharmaceuticals Corporation | $434.92 | 2022-2025 | |
| Lundbeck LLC | $355.96 | 2024-2025 | Rexulti, Vyepti |
| Amgen INC. | $338.69 | 2023-2025 | Otezla, Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $329.27 | 2023-2025 | Spravato, Xarelto |
| Astrazeneca Pharmaceuticals Lp | $324.86 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $253.19 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Idorsia Pharmaceuticals US INC | $244.77 | 2022-2025 | Quviviq, Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $183.58 | 2022-2024 | |
| Lucid Diagnostics INC. | $166.72 | 2022 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.77 | 2022-2025 | Jardiance |
| Phathom Pharmaceuticals, INC. | $155.69 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $153.24 | 2023-2025 | Cologuard Collection Kit |
| Antares Pharma, INC. | $148.82 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Dexcom, INC. | $148.75 | 2024-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $130.55 | 2022-2025 | Verquvo, Steglatro, Belsomra |
| Axsome Therapeutics, INC. | $107.33 | 2023-2025 | Auvelity, Sunosi |
| Sumitomo Pharma America, INC. | $94.68 | 2023-2025 | Gemtesa |
| Radius Health, INC. | $90.06 | 2025 | Tymlos |
| Ironwood Pharmaceuticals, INC | $80.38 | 2023-2024 | Linzess |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $55.38 | 2024-2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company Ltd. | $54.30 | 2022 | |
| Madrigal Pharmaceuticals | $50.63 | 2025 | Rezdiffra |
| Abiomed | $49.43 | 2024 | Impella |
| Xeris Pharmaceuticals, INC. | $48.73 | 2023 | Gvoke Hypopen |
| Pulmonx Corporation | $45.11 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Esperion Therapeutics, INC. | $41.15 | 2024 | Nexletol |
| Shield Therapeutics INC | $35.78 | 2022-2025 | |
| Medtronic, INC. | $35.51 | 2024-2025 | Interstim |
| Bausch Health US, LLC | $32.90 | 2024-2025 | Aplenzin, Wellbutrin |
| Halozyme INC | $28.63 | 2023 | |
| Ibsa Pharma INC. | $28.48 | 2022 | |
| Currax Pharmaceuticals LLC | $28.02 | 2022-2023 | Contrave |
| Eisai INC. | $25.27 | 2025 | |
| Boston Scientific Corporation | $24.06 | 2024 | |
| Scynexis, INC. | $23.02 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $22.04 | 2022 | |
| Cvrx, INC. | $21.95 | 2025 | Barostim Neo System |
| Alexion Pharmaceuticals, INC. | $19.32 | 2023 | Strensiq |
| Horizon Therapeutics Plc | $19.16 | 2023 | Tepezza |
| Takeda Pharmaceuticals U.S.A., INC. | $19.03 | 2022 | |
| Ardelyx, INC. | $18.79 | 2025 | Ibsrela |
| Corcept Therapeutics | $18.12 | 2023 | Korlym |
| Baxter Healthcare | $16.87 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Inspire Medical Systems, INC. | $16.45 | 2025 | Inspire |
| Sanofi Pasteur INC. | $15.97 | 2023 | |
| Genzyme Corporation | $15.90 | 2023 | |
| Avanir Pharmaceuticals, INC. | $14.32 | 2022 | |
| Vanda Pharmaceuticals INC. | $13.65 | 2024 | Fanapt, Hetlioz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.